MedKoo Cat#: 577002 | Name: MDL-27088

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MDL-27088 is an angiotensin-covering enzyme inhibitor.

Chemical Structure

MDL-27088
MDL-27088
CAS#111581-85-2

Theoretical Analysis

MedKoo Cat#: 577002

Name: MDL-27088

CAS#: 111581-85-2

Chemical Formula: C25H30N2O5

Exact Mass: 438.2155

Molecular Weight: 438.52

Elemental Analysis: C, 68.47; H, 6.90; N, 6.39; O, 18.24

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
MDL27088; MDL 27088; MDL-27088
IUPAC/Chemical Name
Pyrido(2,1-a)(2)benzazepine-4-carboxylic acid, 7-((1-carboxy-3-phenylpropyl)amino)-1,2,3,4,6,7,8,12a-octahydro-6-oxo-, (4S-(4alpha,7alpha(R*),12bbeta))-
InChi Key
MFPBDCIKVMSRDU-KJJMTIBFSA-N
InChi Code
InChI=1S/C25H28N2O5/c28-23-20(26-19(24(29)30)14-13-16-7-2-1-3-8-16)15-17-9-4-5-10-18(17)21-11-6-12-22(25(31)32)27(21)23/h1-5,7-10,19-22,26H,6,11-15H2,(H,29,30)(H,31,32)/t19-,20-,21+,22-/m0/s1
SMILES Code
OC(=O)[C@H](CCc1ccccc1)N[C@H]2Cc3ccccc3[C@H]4CCC[C@H](N4C2=O)C(=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 438.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Stuhler JD, Cheng H, Dorrbecker BR. Disposition of a new diacid angiotensin-converting enzyme inhibitor after intravenous administration of drug or prodrug to monkeys and dogs. J Pharm Sci. 1992 Nov;81(11):1071-3. doi: 10.1002/jps.2600811105. PMID: 1447706. 2. Cheng H, Stuhler JD, Dorrbecker BR, Gordon WP. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs. Drug Metab Dispos. 1991 Jan-Feb;19(1):212-7. PMID: 1673401. 3. Giroux E, Beight DW, Dage RC, Flynn GA. Interaction of angiotensin I-converting enzyme with two potent tricyclic inhibitors. J Enzyme Inhib. 1989;2(4):269-77. doi: 10.3109/14756368909088480. PMID: 2542490.